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that result in a switch from the silent to the active state?
What factors are necessary for silencing the genes not
bound by PfSir2? How does the cell limit expression to
a single gene? If subnuclear localization is important
for regulating transcription, what additional levels of
control must be invoked to maintain one gene in the
active state while a tightly linked, and therefore coloca-
lized gene remains silent? As the answers to these and
other similar questions are revealed, invaluable insights
will be gained into what is one of the most puzzling
and important problems regarding the interactions of
malaria parasites with their human hosts.
Kirk W. Deitsch
Department of Microbiology and Immunology
Weill Medical College of Cornell University
1300 York Avenue, Box 62
New York, New York 10021
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Ubiquitin-Mediated Degradation:
aA Mechanism for Fine-Tuning i
nTGF- Signaling
l
d
Effects of the cytokine TGF- can be dampened by i
E3 ubiquitin ligases that target specific Smads, the i
TGF- signal transducers, for proteolytic destruction. M
Two papers in this issue of Cell highlight the impor- s
tance of this mechanism in regulating the in vivo e
effects of TGF-. The first paper identifies and char- S
macterizes a novel Smad4 ubiquitin ligase, and the sec-ond paper redefines the role of a previously identified
Smad1 ubiquitin ligase, Smurf-1 (Dupont et al., 2005;
Yamashita et al., 2005).
Members of the transforming growth factor β (TGF-β)
superfamily signal through a complex system of recep-
tors, Smads, and a constantly growing array of Smad-
and receptor-interacting proteins (reviewed in Shi and
Massague, 2003). The need for this complexity be-
comes clear in light of the diverse roles of the TGF-β
superfamily in nearly all aspects of biology. The impor-
tance of these proteins is evident at the earliest stages
of embryonic development, when the TGF-β superfam-
ily members Nodal and BMP regulate germ-layer speci-
fication. Members of this superfamily then continue to
play critical roles throughout vertebrate development
and control a wide range of physiological processes in
adult life, including immune responses, bone formation,
and wound healing. Furthermore, several components
of the TGF-β signaling pathway can be classified as
tumor suppressor genes that are lost or inactivated in
a variety of epithelial and lymphoid neoplasms. With a
family of cytokines that has the potential to control a
wide range of biological processes in so many cell
types and tissues, multiple layers of tight regulation of
their activities must exist. In this context, two papers in
this issue of Cell explore one of the emerging mecha-
nisms of regulation of TGF-β superfamily signaling,
ubiquitin-mediated proteolysis.
Vertebrate development proceeds through the pro-
gressive restriction of initially pluripotent cells to one of
three primary germ layers: ectoderm, mesoderm, and
endoderm. This complex process is regulated by both
extrinsic contextual and spatial cues, and intrinsic
maternal factors that are asymmetrically distributed
throughout the single-cell embryo. The TGF-β super-
family member Nodal is one such maternal factor (re-
viewed in Whitman, 2001). Nodal is produced in the
vegetal hemisphere of the developing embryo and in-
duces the formation of mesoderm in overlying marginal
zone cells. However, cells immediately adjacent to the
marginal zone in the animal pole of the embryo are re-
sistant to the effects of Nodal and become ectoderm.
Interestingly, in the absence of Nodal, cells that would
have become mesoderm in a normal situation also
acquire an identity of ectoderm, suggesting that ecto-
erm development is determined by a “default” mecha-
ism. Furthermore, this implies that mesoderm devel-
pment is induced specifically by Nodal and that Nodal
ignaling is inhibited in the animal pole by an unknown
actor(s) to allow for ectoderm formation.
Through microinjection of transcripts generated from
blastula stage cDNA library, Piccolo and colleagues
dentified Ectodermin (Ecto) as an ectoderm determi-
ant in the animal pole (Dupont et al., 2005). Ecto is
ocalized to the animal pole of the unfertilized egg and
eveloping embryo, and microinjection of Ecto mRNA
nto the embryos inhibits the formation of mesoderm,
nstead allowing for the development of ectoderm.
oreover, overexpression of Ecto antagonizes all TGF-β
uperfamily signaling in this system. Ecto can block the
ffects of activin, BMP, and overexpression of Smad1,
mad2, and activated type I TGF-β receptors. Further-
ore, repressing the expression of Ecto has the oppo-
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3site effect, leading to promotion of mesoderm forma-
tion at the expense of ectoderm development and
sensitization of cells to the effects of TGF-β superfamily
members. Taken together, the data presented in this
landmark paper provide convincing evidence that Ecto
represents the elusive determinant of ectoderm forma-
tion, acting as a critical inhibitor of all Smad-dependent
TGF-β signaling during vertebrate development.
Ecto is expressed in a variety of mammalian cell lines
and tissues, functioning as a general inhibitor of Smad-
dependent TGF-β signaling (Dupont et al., 2005). In the
colon, epithelial cells are constantly being renewed,
with progenitor cells proliferating at the base of colonic
crypts and migrating to the luminal end while they start
to take on the morphologic characteristics of differenti-
ated cells. This process is tightly controlled by a deli-
cate balance between proliferation and differentiation
of the migrating cells. The expression pattern of Ecto
in the normal colon tissue indicates that it may be a
factor that helps to regulate this balancing act. Ecto
expression is limited to the base of colonic crypts
where the progenitor cells are located, suggesting that
Ecto blocks the growth-suppressive effects of TGF-β
on these cells, allowing them to proliferate. On the
other hand, Ecto expression is absent from differenti-
ated cells, presumably allowing these cells to remain
sensitive to the antiproliferative effects of TGF-β.
During neoplastic transformation, the normal balance
between proliferation and differentiation in the colonic
epithelium is lost. Intriguingly, in all the tumor samples
examined, Ecto expression was present throughout the
tumor mass, implicating the constant repression of the
antiproliferative effects of TGF-β in the tumor cells.
While the mechanism through which Ecto expression is
retained in the tumor cells remains unknown, one can
speculate that interaction between the deregulated Wnt
pathway and TGF-β signaling may play a role in this
process. Since the Wnt signaling pathway is frequently
activated due to mutations in APC and β-catenin during
colon tumor development, disregulation of Ecto ex-
pression may be a direct consequence of the activated
Wnt pathway. This may explain the previously de-
scribed functional synergy between the loss of APC
function and Smad4 deficiency in inducing colon can-
cer development (Takaku et al., 1998). This type of cross-
talk between the Wnt and TGF-β signaling pathways via
the regulation of Ecto expression may also play a criti-
cal role during early embryonic development since both
Wnt and TGF-β superfamily members function as im-
portant regulators of various developmental processes.
Mechanistically, Ecto, which is a RING-type ubiquitin
ligase localized in the nucleus, can bind specifically to
Smad4, leading to its ubiquitination and proteosome-
mediated degradation and consequently blocking Smad-
dependent TGF-β signaling. Ecto may also attenuate
TGF-β signaling by changing the nuclear-cytoplasmic
distribution pattern of ubiquitinated Smad4 through re-
ducing its nuclear presence. Thus, with or without en-
hancing ubiquitin-mediated degradation of Smad4,
Ecto may actively promote nuclear export of ubiquiti-
nated Smad4 and/or inhibit nuclear import of the post-
translationally modified protein. Regardless of the pre-
cise mechanism, Ecto can fine-tune TGF-β responses
by decreasing the amount of nuclear Smad4 that mayparticipate in the transcriptional regulation of target
genes. In the context of Xenopus development, this
fine-tuning comes in the form of a complete abrogation
of the effects of Nodal. In the context of tumor develop-
ment, elevated Ecto expression could blunt Smad4-
dependent antiproliferative effects in both the presence
and absence of TGF-β. Thus, Ecto acts as a regulator
of TGF-β signaling by decreasing the basal or threshold
level of Smad4 available for action in the cytoplasm and
in the meantime shutting down ligand-independent
nuclear activity of Smad4 being actively shuttled be-
tween nucleus and cytoplasm.
Ecto is not the first ubiquitin ligase that has been im-
plicated as a regulator of TGF-β signaling, as several
other R-Smad and Smad4 ubiquitin ligases have been
described. The first of these was Smurf-1 (Smad ubiq-
uitination regulatory factor-1), a protein identified in a
two-hybrid screen for Smad1-interacting proteins (Zhu
et al., 1999). Smurf-1 is a member of the HECT family
of E3 ubiquitin ligases, and it binds to and causes the
ubiquitin-mediated degradation of Smad1 and Smad5,
independent of receptor-mediated phosphorylation of
these BMP-specific R-Smads. While overexpression
studies have shown the potential of Smurf-1 to block
BMP-regulated events in both Xenopus development
and mammalian cells, it is unclear if these R-Smads are
the physiological targets of Smurf-1. To address this
question, Zhang and colleagues generated and charac-
terized mice harboring a targeted disruption of the
Smurf-1 gene (Yamashita et al., 2005). Smurf-1-null
mice are viable and survive to adulthood, suggesting
that Smurf-1 is not required for normal embryonic de-
velopment. Importantly, cells from Smurf-1-null mice
exhibit normal levels of the BMP receptors, Smad1,
Smad2, Smad3, Smad5, and Runx2, all of which are
previously defined as targets of Smurf-1. This is cer-
tainly an unexpected result for the loss of a suspected
Smad1/5 ubiquitin ligase, although it may be partially
explained by the upregulation of Smurf-2, a closely re-
lated homolog of Smurf-1 (Kavsak et al., 2000; Lin et
al., 2000; Zhang et al., 2001). Since these two E3 ligases
have been shown to possess overlapping functions,
Smurf-2 may be able to compensate for the loss of
Smurf-1, a critical point that needs to be addressed
with the generation of Smurf-1/Smurf-2 double defi-
cient mice or cells.
Ironically, BMP signaling is augmented in Smurf-1-
null mice, as would have been initially predicted for the
loss of an E3 ligase that targets components of the
BMP pathway. Specifically, Smurf-1-null mice exhibit an
increase in bone mass that results from enhanced ac-
tivity of osteoblasts, which become sensitized to the
effects of BMP. This occurs despite the normal levels
of Smad1 and Smad5 detected in osteoblasts. Through
a number of experiments, Zhang and colleagues were
able to attribute this effect to an increased basal activ-
ity of JNK. JNK is a MAP kinase that phosphorylates
the Jun family of transcription factors to regulate AP-1-
mediated transcription. JNK itself is regulated through
phosphorylation, and in Smurf-1-null mice, JNK is con-
stitutively phosphorylated and activated. Experimen-
tally blocking JNK activity desensitizes Smurf-1-null
osteoblasts to BMP, suggesting that JNK is necessary
for manifesting the effects of Smurf-1 loss in these
Cell
4Scells. Furthermore, retroviral-mediated introduction of a
constitutively active JNK mimics the sensitization to
DBMP seen in Smurf-1-null cells, indicating that JNK ac-
R
tivation is sufficient for the development of the pheno-
K
type. A number of kinases that act upstream of JNK T
and are capable of causing its phosphorylation contain L
“PY” motifs that interact with a specific region, the WW 3
domain, of the Smurf family of proteins. Of these, S
MEKK2 was found to be a binding partner for Smurf-1, T
and a phosphorylated form of MEKK2 was defined as T
a target for Smurf-1-mediated ubiquitination and deg- W
radation. Thus, the absence of Smurf-1 causes the ac- Y
cumulation of MEKK2, resulting in activation of JNK, a
an event that is both necessary and sufficient for BMP Z
sensitization in osteoblasts. r
This study is of significance because it highlights the Z
(important contributions of Smad-independent kinase-
cascade signaling pathways to the elicitation of spe-
Dcific biological responses to the TGF-β superfamily by
convincingly demonstrating a mechanistic link between
the activity of Smurf-1 and MEKK2 degradation in the
context of BMP signaling. However, the molecular con-
nection between JNK activation and BMP sensitization
remains to be elucidated. AP-1 family members and
Smads are known to act coordinately on a number of
promoters. By augmenting AP-1 activity, transcription
of those genes could be sensitized to the Smads, con-
sequently providing an explanation to the phenotype
observed in the Smurf-1-null mice. On the other hand,
JNK has previously been shown to be activated directly
by TGF-β stimulation via an unknown mechanism, al-
though a direct activation of JNK by BMP may not be
the molecular basis for the sensitizing effects observed
in Smurf-1-null cells.
In summary, findings presented in these two articles
highlight the prominence and likely the generality of
ubiquitin-mediated degradation of components of TGF-β
signaling pathways as a critical mechanism to control
and fine-tune biological responses to the TGF-β super-
family. The discovery of Ecto as a determinant of ecto-
derm formation during embryonic development and
revelation of its potential role in modulating tissue ho-
meostasis firmly establish the functional significance of
this mechanism. The characterization of MEKK2 as a
physiological target of Smurf-1 provides fresh evidence
for the importance of Smad-independent signaling
pathways in determining the ultimate nature of biologi-
cal responses to this superfamily of cytokines. In the
meantime, it also serves as a cautionary note to the use
of overexpression as the sole approach to functionally
define the physiological targets of the ubiquitin ligases.
In the next phase, the challenge will be the determina-
tion of physiological roles of the ever-growing number
of ubiquitin ligases that are biochemically linked to the
signaling pathways of TGF-β superfamily in specific bi-
ological contexts and processes.
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